SCHEMBL3475623

SCHEMBL3475623

CCCCc1c2nc(c(CCCC)c3ccc([nH]3)c(CCCC)c3nc(c(CCCC)c4ccc1[nH]4)C=C3)C=C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TERT O14746 2/20 0.40
▸ PARP1 P09874 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ GABRP O00591 1/20 0.36
▸ GABRD O14764 1/20 0.36
▸ GABRA1 P14867 1/20 0.36
▸ IDO1 P14902 1/20 0.36
▸ GABRB1 P18505 1/20 0.36
▸ GABRG2 P18507 1/20 0.36
▸ GABRB3 P28472 1/20 0.36
▸ GABRA5 P31644 1/20 0.36
▸ GABRA3 P34903 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1194293 0.95 KCNH2 (0.39) MAPTHTTKDM4EHSD17B10CYP1A2
SCHEMBL15468129 0.93 KCNH2 (0.42) MAPTHTTKDM4EHSD17B10TERT
SCHEMBL8601755 0.93 KCNH2 (0.42) MAPTHTTKDM4EHSD17B10TERT
SCHEMBL9438134 0.93 KCNH2 (0.42) MAPTHTTKDM4EHSD17B10TERT
SCHEMBL433614 0.93 KCNH2 (0.42) MAPTHTTKDM4EHSD17B10TERT
SCHEMBL9366416 0.89 TERT (0.41) KDM4EHSD17B10TSHRTERTALDH1A1
SCHEMBL31392759 0.89 TERT (0.41) KDM4EHSD17B10TSHRTERTALDH1A1
SCHEMBL7262879 0.86 TERT (0.34) MAPTHTTKDM4EHSD17B10CYP1A2
SCHEMBL6003423 0.86 TERT (0.34) MAPTHTTKDM4EHSD17B10CYP1A2
SCHEMBL6003931 0.85 TERT (0.33) MAPTHTTKDM4EHSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304283-B2 Method for producing organic electronic device including converting a precursor for a semiconductor layer MITSUBISHI CHEMICAL CORPORATION (JP) 2012-11-06 — — US disclosed
US-8304283-B2 Method for producing organic electronic device including converting a precursor for a semiconductor layer MITSUBISHI CHEMICAL CORPORATION (JP) 2012-11-06 — — US disclosed
WO-2010088723-A1 DYE COMPOSITION FOR USE IN PHOTOELECTRIC MATERIAL UNIVERSITY OF WOLLONGONG (AU) 2010-08-12 — — WO disclosed
US-20100029041-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRONIC DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2010-02-04 — — US disclosed
US-20100029041-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRONIC DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2010-02-04 — — US disclosed
US-20080283122-A1 Beta-Substituted Porphyrins CAMPBELL WAYNE MASON 2008-11-20 — — US disclosed
US-20070145361-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRONIC DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2007-06-28 — — US disclosed
US-20070145361-A1 ORGANIC SEMICONDUCTOR MATERIAL AND ORGANIC ELECTRONIC DEVICE MITSUBISHI CHEMICAL CORPORATION (JP) 2007-06-28 — — US disclosed
US-7193237-B2 Organic semiconductor material and organic electronic device MITSUBISHI CHEMICAL CORPORATION (JP) 2007-03-20 — — US disclosed
US-7193237-B2 Organic semiconductor material and organic electronic device MITSUBISHI CHEMICAL CORPORATION (JP) 2007-03-20 — — US disclosed
WO-2006038823-A1 BETA-SUBSTITUTED PORPHYRINS MASSEY UNIVERSITY (NZ) 2006-04-13 — — WO disclosed
EP-0376231-B1 Optical recording media MITSUI TOATSU CHEMICALS (JP) 1994-09-07 — — EP disclosed
US-5196231-A Polysiloxanes MITSUI TOATSU CHEMICALS, INC. (JP) 1993-03-23 — — US disclosed
US-5132153-A Organic dye, polysiloxane layer MITSUI TOATSU CHEMICALS, INC. (JP) 1992-07-21 — — US disclosed
EP-0376231-A2 Optical recording media MITSUI TOATSU CHEMICALS, Inc. (JP) 1990-07-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080283122-A1 Beta-Substituted Porphyrins PPOX, HMBS, CRY1 MAPT 1304/4885HTT 1216/4885KDM4E 621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback